Breathing in a new way to see lungs: MRI with inhaled gas
NCT ID NCT07305532
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new MRI technique that uses an inhaled gas (perfluoropropane) to create detailed images of the lungs. Researchers will enroll 200 healthy adults aged 18 to 85 to improve the hardware and software needed for this imaging. The goal is to make lung scans clearer and safer without using radiation.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- perfluoropropane gas
- What this could lead to
- If successful, this could lead to a safer, radiation-free way to image lung function, helping diagnose lung diseases earlier.
- What could go wrong
- This is an early development study in healthy volunteers, so it may not translate to patients. The technique is still being refined and may not improve current imaging methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Participants eligible for inclusion in this study must meet all of the following criteria: 1. Patient understands study procedures and is willing to participate in the study as indicated by the patient's signature. 2. Provision of written, informed consent prior to any study specific procedures. 3. Males and females aged 18 to 85 years. 4. Participant must be able to perform a breath-hold for 16s. 5. Participant has a BMI between 18 and 40 6. Participant must be able to perform reproducible pulmonary function tests (i.e., the 3 best acceptable spirograms have forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) values that do not vary more than 5% of the largest value or more than 100 ml, whichever is greater) 7. Participants are judged to be in stable health on the basis of medical history Exclusion Criteria: Participants fulfilling any of the following criteria are not eligible for inclusion in this study: 1. Patient has an MR incompatible implanted mechanically, electrically, or magnetically activated device or any metal in their body which cannot be removed, including but not limited to pacemakers, neurostimulators, biostimulators, implanted insulin pumps, aneurysm clips, bioprosthesis, artificial limb, metallic fragment or foreign body, shunt, surgical staples (including clips or metallic sutures and/or ear implants) (at the discretion of the MRI Technologist). 2. In the investigator's opinion, subject suffers from any physical, psychological or other condition(s) that might prevent performance of the MRI or CT, such as severe claustrophobia. 3. Participants who are pregnant, breastfeeding or have a positive pregnancy test at initial screening visit. 4. Participant is unable to perform spirometry maneuvers. 5. Participant is unable to perform MRI and CT breath-hold maneuvers. 6. Participant has a history of chronic or acute respiratory disease 7. FEV1 \<70% 8. Participant has a history of cardiovascular disorders including coronary insufficiency, cardiac arrhythmias, severe hypertension (≥160 over ≥100) 9. Participant has a daytime room air oxygen saturation ≤ 92% ± 2% while supine
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy volunteers - male and female are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
St Joseph's Healthcare London
London, Ontario, N6A 4V2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can paying attention to your body rewire your brain waves in 30 minutes?
- New lung imaging technique uses inhaled gas to see inside your lungs
- Quinoa cookie trial: a tasty way to fight obesity?
- New RNA drug ORN252 tested in humans for first time
- Scientists test drug binding in healthy lungs to guide future treatments
- New drug QLS7305 tested in healthy volunteers – first step for future therapies